Cargando…

Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia

OBJECTIVE: To study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyuan, Guo, Bin, Zhao, Ke, Yang, Linfeng, Chen, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086317/
https://www.ncbi.nlm.nih.gov/pubmed/37056688
http://dx.doi.org/10.3389/fnagi.2023.1148518
_version_ 1785022124852772864
author Wang, Yuanyuan
Guo, Bin
Zhao, Ke
Yang, Linfeng
Chen, Tao
author_facet Wang, Yuanyuan
Guo, Bin
Zhao, Ke
Yang, Linfeng
Chen, Tao
author_sort Wang, Yuanyuan
collection PubMed
description OBJECTIVE: To study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum biomarkers for evaluating cognitive functional impairment in PE patients. METHODS: Sixty-eight patients with PE, 48 NPHCs, and 30 PHCs were included. Cognitive functional status was assessed using standardized Symbol Digit Modalities Test (SDMT) and Montreal Cognitive Assessment (MoCA) scales. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum P-tau181 and T-tau protein. The concentration of serum P-tau181 and T-tau protein were compared by one-way analysis of variance in the three groups of subjects. The correlation between P-tau181, T-tau, and SDMT was explore by multiple linear regression analysis. The areas under the receiver operating characteristic (ROC) curves of serum P-tau181 and SDMT were calculated to predict the cognitive level of subjects. RESULTS: PE patients significantly had lower scores on SDMT (47.97 ± 7.54) and MoCA (28.00 ± 2.00) than normotensive PHCs (30.00 ± 1.25, 54.73 ± 8.55, respectively). The significant difference was found in serum P-tau181 protein levels among the three groups [H(K) = 19.101, P < 0.001]. Serum P-tau181 was thicker in PE patients than PHCs or NPHCs (both P < 0.05). According to the ROC curve, T-tau had no statistical significance in predicting the ability of cognizance, while P-tau181 and SDMT had. The DeLong test showed that P-tau181 was better than T-tau in predicting the ability of cognizance (P < 0.05). CONCLUSION: The patients with PE have occurred the decline of cognitive function during pregnancy. The high level of serum P-tau181 can be used as a clinical laboratory indication for non-invasive assessment of cognitive functional impairment in PE patients.
format Online
Article
Text
id pubmed-10086317
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100863172023-04-12 Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia Wang, Yuanyuan Guo, Bin Zhao, Ke Yang, Linfeng Chen, Tao Front Aging Neurosci Neuroscience OBJECTIVE: To study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum biomarkers for evaluating cognitive functional impairment in PE patients. METHODS: Sixty-eight patients with PE, 48 NPHCs, and 30 PHCs were included. Cognitive functional status was assessed using standardized Symbol Digit Modalities Test (SDMT) and Montreal Cognitive Assessment (MoCA) scales. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum P-tau181 and T-tau protein. The concentration of serum P-tau181 and T-tau protein were compared by one-way analysis of variance in the three groups of subjects. The correlation between P-tau181, T-tau, and SDMT was explore by multiple linear regression analysis. The areas under the receiver operating characteristic (ROC) curves of serum P-tau181 and SDMT were calculated to predict the cognitive level of subjects. RESULTS: PE patients significantly had lower scores on SDMT (47.97 ± 7.54) and MoCA (28.00 ± 2.00) than normotensive PHCs (30.00 ± 1.25, 54.73 ± 8.55, respectively). The significant difference was found in serum P-tau181 protein levels among the three groups [H(K) = 19.101, P < 0.001]. Serum P-tau181 was thicker in PE patients than PHCs or NPHCs (both P < 0.05). According to the ROC curve, T-tau had no statistical significance in predicting the ability of cognizance, while P-tau181 and SDMT had. The DeLong test showed that P-tau181 was better than T-tau in predicting the ability of cognizance (P < 0.05). CONCLUSION: The patients with PE have occurred the decline of cognitive function during pregnancy. The high level of serum P-tau181 can be used as a clinical laboratory indication for non-invasive assessment of cognitive functional impairment in PE patients. Frontiers Media S.A. 2023-03-28 /pmc/articles/PMC10086317/ /pubmed/37056688 http://dx.doi.org/10.3389/fnagi.2023.1148518 Text en Copyright © 2023 Wang, Guo, Zhao, Yang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Wang, Yuanyuan
Guo, Bin
Zhao, Ke
Yang, Linfeng
Chen, Tao
Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_full Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_fullStr Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_full_unstemmed Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_short Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_sort correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086317/
https://www.ncbi.nlm.nih.gov/pubmed/37056688
http://dx.doi.org/10.3389/fnagi.2023.1148518
work_keys_str_mv AT wangyuanyuan correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT guobin correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT zhaoke correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT yanglinfeng correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT chentao correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia